A method of treating an autoimmune disease (for example, Systemic Lupus Erythematosus) comprises administering to the subject a treatment effective amount of a histone hyperacetylating agent, or a pharmaceutically acceptable salt thereof. Methods of screening compounds useful for the treatment of autoimmune disease are also disclosed.
CROSS-REFERENCE TO RELATED APPLICATION
The present application is a divisional of U.S. patent application Ser. No. 10/187,586, filed Jul. 2, 2002, which is a divisional of U.S. patent application Ser. No. 09/718,195, filed Nov. 20, 2000 (now abandoned), the disclosures of which are incorporated herein by reference in their entireties.
